Literature DB >> 35915767

Spatially coherent modeling of 3D FDG-PET data for assessment of intratumoral heterogeneity and uptake gradients.

Eric Wolsztynski1,2, Finbarr O'Sullivan1,2, Janet F Eary3.   

Abstract

Purpose: Radiomics have become invaluable for non-invasive cancer patient risk prediction, and the community now turns to exogenous assessment, e.g., from genomics, for interpretability of these agnostic analyses. Yet, some opportunities for clinically interpretable modeling of positron emission tomography (PET) imaging data remain unexplored, that could facilitate insightful characterization at voxel level. Approach: Here, we present a novel deformable tubular representation of the distribution of tracer uptake within a volume of interest, and derive interpretable prognostic summaries from it. This data-adaptive strategy yields a 3D-coherent and smooth model fit, and a profile curve describing tracer uptake as a function of voxel location within the volume. Local trends in uptake rates are assessed at each voxel via the calculation of gradients derived from this curve. Intratumoral heterogeneity can also be assessed directly from it.
Results: We illustrate the added value of this approach over previous strategies, in terms of volume rendering and coherence of the structural representation of the data. We further demonstrate consistency of the implementation via simulations, and prognostic potential of heterogeneity and statistical summaries of the uptake gradients derived from the model on a clinical cohort of 158 sarcoma patients imaged with F 18 -fluorodeoxyglucose-PET, in multivariate prognostic models of patient survival. Conclusions: The proposed approach captures uptake characteristics consistently at any location, and yields a description of variations in uptake that holds prognostic value complementarily to structural heterogeneity. This creates opportunities for monitoring of local areas of greater interest within a tumor, e.g., to assess therapeutic response in avid locations.
© 2022 Society of Photo-Optical Instrumentation Engineers (SPIE).

Entities:  

Keywords:  heterogeneity; positron emission tomography; sarcoma; spatial statistics; tumor characterization; uptake gradient

Year:  2022        PMID: 35915767      PMCID: PMC9334646          DOI: 10.1117/1.JMI.9.4.045003

Source DB:  PubMed          Journal:  J Med Imaging (Bellingham)        ISSN: 2329-4302


  26 in total

1.  Radiogenomics: bridging imaging and genomics.

Authors:  Zuhir Bodalal; Stefano Trebeschi; Thi Dan Linh Nguyen-Kim; Winnie Schats; Regina Beets-Tan
Journal:  Abdom Radiol (NY)       Date:  2019-06

Review 2.  Neuro-Oncology and Radiogenomics: Time to Integrate?

Authors:  A Lasocki; M A Rosenthal; S J Roberts-Thomson; A Neal; K J Drummond
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-10       Impact factor: 3.825

Review 3.  Background, current role, and potential applications of radiogenomics.

Authors:  Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris
Journal:  J Magn Reson Imaging       Date:  2017-11-02       Impact factor: 4.813

4.  18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.

Authors:  Mathieu Hatt; Mohamed Majdoub; Martin Vallières; Florent Tixier; Catherine Cheze Le Rest; David Groheux; Elif Hindié; Antoine Martineau; Olivier Pradier; Roland Hustinx; Remy Perdrisot; Remy Guillevin; Issam El Naqa; Dimitris Visvikis
Journal:  J Nucl Med       Date:  2014-12-11       Impact factor: 10.057

5.  Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome.

Authors:  Janet F Eary; Ernest U Conrad; Janet O'Sullivan; Douglas S Hawkins; Scott M Schuetze; Finbarr O'Sullivan
Journal:  J Bone Joint Surg Am       Date:  2014-01-15       Impact factor: 5.284

Review 6.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

7.  Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.

Authors:  Joo Hyun O; Brandon S Luber; Jeffrey P Leal; Hao Wang; Vanessa Bolejack; Scott M Schuetze; Lawrence H Schwartz; Lee J Helman; Denise Reinke; Laurence H Baker; Richard L Wahl
Journal:  J Nucl Med       Date:  2016-01-21       Impact factor: 10.057

8.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?

Authors:  Fergus Davnall; Connie S P Yip; Gunnar Ljungqvist; Mariyah Selmi; Francesca Ng; Bal Sanghera; Balaji Ganeshan; Kenneth A Miles; Gary J Cook; Vicky Goh
Journal:  Insights Imaging       Date:  2012-10-24

9.  The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.

Authors:  Alex Zwanenburg; Martin Vallières; Mahmoud A Abdalah; Hugo J W L Aerts; Vincent Andrearczyk; Aditya Apte; Saeed Ashrafinia; Spyridon Bakas; Roelof J Beukinga; Ronald Boellaard; Marta Bogowicz; Luca Boldrini; Irène Buvat; Gary J R Cook; Christos Davatzikos; Adrien Depeursinge; Marie-Charlotte Desseroit; Nicola Dinapoli; Cuong Viet Dinh; Sebastian Echegaray; Issam El Naqa; Andriy Y Fedorov; Roberto Gatta; Robert J Gillies; Vicky Goh; Michael Götz; Matthias Guckenberger; Sung Min Ha; Mathieu Hatt; Fabian Isensee; Philippe Lambin; Stefan Leger; Ralph T H Leijenaar; Jacopo Lenkowicz; Fiona Lippert; Are Losnegård; Klaus H Maier-Hein; Olivier Morin; Henning Müller; Sandy Napel; Christophe Nioche; Fanny Orlhac; Sarthak Pati; Elisabeth A G Pfaehler; Arman Rahmim; Arvind U K Rao; Jonas Scherer; Muhammad Musib Siddique; Nanna M Sijtsema; Jairo Socarras Fernandez; Emiliano Spezi; Roel J H M Steenbakkers; Stephanie Tanadini-Lang; Daniela Thorwarth; Esther G C Troost; Taman Upadhaya; Vincenzo Valentini; Lisanne V van Dijk; Joost van Griethuysen; Floris H P van Velden; Philip Whybra; Christian Richter; Steffen Löck
Journal:  Radiology       Date:  2020-03-10       Impact factor: 29.146

10.  Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.

Authors:  Michael Soussan; Fanny Orlhac; Marouane Boubaya; Laurent Zelek; Marianne Ziol; Véronique Eder; Irène Buvat
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.